Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107640
Filing Date
2025-11-06
Accepted
2025-11-06 14:33:28
Documents
103
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cyrx-20250930x10q.htm   iXBRL 10-Q 3314662
2 EX-31.1 cyrx-20250930xex31d1.htm EX-31.1 14164
3 EX-31.2 cyrx-20250930xex31d2.htm EX-31.2 13050
4 EX-32.1 cyrx-20250930xex32d1.htm EX-32.1 17160
5 GRAPHIC cyrx-20250930x10q004.jpg GRAPHIC 8145
  Complete submission text file 0001104659-25-107640.txt   15190855

Data Files

Seq Description Document Type Size
6 EX-101.SCH cyrx-20250930.xsd EX-101.SCH 79605
7 EX-101.CAL cyrx-20250930_cal.xml EX-101.CAL 110963
8 EX-101.DEF cyrx-20250930_def.xml EX-101.DEF 380747
9 EX-101.LAB cyrx-20250930_lab.xml EX-101.LAB 726645
10 EX-101.PRE cyrx-20250930_pre.xml EX-101.PRE 585148
106 EXTRACTED XBRL INSTANCE DOCUMENT cyrx-20250930x10q_htm.xml XML 3491113
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34632 | Film No.: 251457516
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)